MENU
GET LISTED
GET LISTED
SHOW ALLPOPULAR CATEGORIES

Compare Jifflenow vs Easy Projects

SCORES FEATURES PRICING PRICING MODEL INTEGRATIONS

What is better Jifflenow or Easy Projects? You have so many Collaboration Software solutions in today’s market that selecting the best product is often frustrating. On our comparison page, you can actually review the features, stipulations, available plans, and more details of Jifflenow and Easy Projects.

It’s also possible to check their score (8.8 for Jifflenow vs. 8.8 for Easy Projects) and user satisfaction level (N/A% for Jifflenow vs. 97% for Easy Projects). The scores and ratings offer you an overall idea how both of these software products perform. Moreover, find out if the software can integrate with the company’s current business apps to ensure greater productivity.

Currently, the best services in our Collaboration Software category are: Wrike, Smartsheet, monday.com.

In the event you continue having doubts about which service will perform best in your case it might be a sound idea to take a look at each service’s social metrics. Such metrics are usually a way to see how popular every app is and how large is its online presence. For example Jifflenow Twitter profile has currently 357 followers. At the same time Easy Projects Twitter is followed by 1014 people.

Page last modified

Why is FinancesOnline free? Why is FinancesOnline free?

FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.